| Also known as |
DSIP Peptide |
| Blood pressure |
Generally does not affect blood pressure |
| Chemical name |
Delta Sleep-Inducing Peptide |
| Dosage (medical) |
25 mcg intranasal or 0.5–1.0 mg intravenous at bedtime |
| Dosage (sports) |
Not established |
| Effects |
Promotes sleep, modulates endocrine regulation, and enhances a sense of well-being |
| Formula |
C35H48N10O15 |
| Half-life |
Approximately 0.6 hours |
| Hepatotoxicity |
Not hepatotoxic |
| Lab Test |
Specialized assays for DSIP detection and quantification |
| Main action |
Modulates neurotransmission, induces sleep |
| Raw Material |
Human Growth Hormone |
| Side effects |
Possible mild headaches, dizziness, and nausea |
| Storage conditions |
Store in a cool, dry place away from light |
| Substance class |
Peptide |
| Trade name |
Not available under a specific trade name |
| Use in sports |
Primarily for recovery and improved sleep quality |
| Water Retention |
Minimal |
| Manufacturer |
Generic blue top |
| Packing |
DSIP 5mg |
